Suppr超能文献

RSR13是一种血红蛋白-氧亲和力的合成调节剂,可增强麻醉犬顿抑心肌的恢复。

RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.

作者信息

Pagel P S, Hettrick D A, Montgomery M W, Kersten J R, Steffen R P, Warltier D C

机构信息

Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.

出版信息

J Pharmacol Exp Ther. 1998 Apr;285(1):1-8.

PMID:9535987
Abstract

RSR13 (2-[4-[[(3, 5-dimethylanilino)carbonyl]methyl]phenoxyl]-2-methylpropr ionic acid) is a synthetic allosteric modifier of oxygen (O2)-hemoglobin affinity that increases O2 release to tissue by allosterically stabilizing deoxyhemoglobin. We tested the hypothesis that RSR13 enhances the functional recovery of stunned myocardium in barbiturate-anesthetized dogs instrumented for measurement of left ventricular (LV) and aortic blood pressure, LV +dP/dtmax and subendocardial segment shortening (%SS) in ischemic [left anterior descending (LAD) coronary artery] and normal (left circumflex coronary artery) zones. The partial pressure of oxygen and the Hill coefficient at 50% saturation (P50 and n50, respectively) were determined in arterial blood samples by multiple point tonometry and nonlinear regression analysis. Coronary collateral blood flow in the LAD zone was quantified with radioactive microspheres. Dogs received intravenous vehicle (0.45% saline) or one of two doses of RSR13 (100 or 150 mg.kg-1 bolus followed by a 0.50 or 0.75 mg.kg-1.min-1 infusion, respectively) in a random manner. All dogs were subjected to five 5-min periods of LAD occlusion separated by 5-min periods of reperfusion and followed by 180 min of final reperfusion during which hemodynamics, %SS, arterial blood gases, P50 and n50 were determined at selected intervals. RSR13 caused no hemodynamic effects and coronary collateral blood flow was equivalent among groups. RSR13 increased P50 (+40 +/- 4% for the high dose) and decreased n50 (-31 +/- 2% for the high dose). LAD occlusion caused regional dyskinesia during each 5-min occlusion. Enhanced recovery of %SS by 180 min after final reperfusion was observed in dogs treated with high-dose RSR13 (47 +/- 9% of base line) but not low-dose RSR13 (10 +/- 18% of base line) or vehicle alone (2 +/- 16% of base line). The results suggest that high-dose RSR13 improves the recovery of stunned myocardium throughout reperfusion in open-chest dogs. These findings may be related to increases in O2 availability to ischemic myocardium resulting from RSR13-induced stabilization of the deoxy form of hemoglobin.

摘要

RSR13(2-[4-[[(3,5-二甲基苯胺基)羰基]甲基]苯氧基]-2-甲基丙酸)是一种氧(O₂)-血红蛋白亲和力的合成变构调节剂,它通过变构稳定脱氧血红蛋白来增加O₂向组织的释放。我们检验了这样一个假设:RSR13可增强巴比妥麻醉犬的顿抑心肌功能恢复,这些犬已安装仪器用于测量左心室(LV)和主动脉血压、LV +dP/dtmax以及缺血区[左前降支(LAD)冠状动脉]和正常区(左旋支冠状动脉)的心内膜下节段缩短率(%SS)。通过多点眼压测量法和非线性回归分析测定动脉血样本中的氧分压和50%饱和度时的希尔系数(分别为P50和n50)。用放射性微球定量LAD区的冠状动脉侧支血流量。犬随机接受静脉注射溶媒(0.45%盐水)或两种剂量的RSR13之一(分别为100或150 mg·kg⁻¹推注,随后分别以0.50或0.75 mg·kg⁻¹·min⁻¹输注)。所有犬均经历5个5分钟的LAD闭塞期,期间间隔5分钟的再灌注期,随后是180分钟的最终再灌注期,在此期间在选定的时间间隔测定血流动力学、%SS、动脉血气、P50和n50。RSR13未引起血流动力学效应,且各组间冠状动脉侧支血流量相当。RSR13使P50升高(高剂量组升高40±4%),使n50降低(高剂量组降低31±2%)。每次5分钟的LAD闭塞均导致局部运动障碍。在高剂量RSR13治疗的犬中观察到最终再灌注180分钟后%SS的恢复增强(为基线的47±9%),而低剂量RSR13组(为基线的10±18%)或单独使用溶媒组(为基线的2±16%)则未观察到。结果表明,高剂量RSR13可改善开胸犬整个再灌注过程中顿抑心肌的恢复。这些发现可能与RSR⁃13诱导的血红蛋白脱氧形式的稳定导致缺血心肌的O₂供应增加有关。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验